Search

Your selection

None

Filter by content type

Filter by content year

News

Vaxart Announces Agreement with hVIVO to Develop World’s First Human Omicron Challenge Model

June 30, 2022 - … hVIVO to Develop World’s First Human Omicron Challenge Model Vaxart Announces Agreement with hVIVO to Develop World’s First Human Omicron Challenge Model June 30, 2022 General Model will be used in Vaxart’s Phase II Omicron Challenge … hVIVO to Develop World’s First Human Omicron Challenge Model …
News

New Preclinical Data Demonstrate Two of Vaxart’s COVID-19 Vaccine Candidates Protect Against Omicron

June 3, 2022 - … protect against Omicron challenge in a key preclinical model.” The data reported today are from a study in which the … vaccine candidates were compared in a hamster challenge model. Animals were immunized mucosally on days zero and 28 … These findings demonstrate that in this preclinical model both vaccine candidates protect against the Omicron …
News

Vaxart Announces the Publication of Studies in the Peer-Reviewed Journal Science Translational Medicine That Suggest Mucosal Immunization Could Decrease SARS-CoV-2 Transmission

May 19, 2022 - … disease and decreased airborne transmission in a hamster model.” The publication also reported results from the Phase … disease and decreased airborne transmission in a hamster model.” The publication also reported results from the Phase … disease and decreased airborne transmission in a hamster model.” The publication also reported results from the Phase …
News

Vaxart Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results

February 24, 2022 - … the airborne transmission of SARS-CoV-2 virus in an animal model and suggested the vaccine candidate would trigger … the airborne transmission of SARS-CoV-2 virus in an animal model and suggested the vaccine candidate would trigger … the airborne transmission of SARS-CoV-2 virus in an animal model and suggested the vaccine candidate would trigger …
News

Stanford Scientists First To Identify New Cellular Correlates of Protection Against Influenza for an Oral Flu Vaccine Developed by Vaxart

News

Vaxart Announces Publication of Complete Data from Preclinical COVID-19 Oral Vaccine Hamster Challenge Study in Journal of Infectious Diseases

November 16, 2021 - … titers in the lung and protects against COVID-19 in animal model SOUTH SAN FRANCISCO, Calif. , Nov. 16, 2021 (GLOBE … the airborne transmission of SARS-CoV-2 virus in a hamster model. These results are consistent with those … SARS-CoV-2 at week 8. Hamsters are considered an excellent model for assessing COVID-19 infection because they can be …
News

Vaxart Provides Business Update and Reports Third Quarter 2021 Financial Results

November 4, 2021 - … transmission of SARS-CoV-2 virus in a hamster preclinical model. The Company also expanded its research and … the airborne transmission of SARS-CoV-2 virus in a hamster model. These results are consistent with those … transmission of SARS-CoV-2 virus in a hamster preclinical model. The Company also expanded its research and …
News

Vaxart Doses First Subject in Phase II COVID-19 Oral Tablet Vaccine Clinical Trial

October 26, 2021 - … the airborne transmission of SARS-CoV-2 virus in an animal model and suggested the vaccine candidate would support … the airborne transmission of SARS-CoV-2 virus in an animal model and suggested the vaccine candidate would support … the airborne transmission of SARS-CoV-2 virus in an animal model and suggested the vaccine candidate would support …
News

New Duke University-led Study Shows That Vaxart's Oral COVID-19 Vaccine Candidate Reduces Airborne Transmission of SARS-CoV-2 Infection in Animal Model

October 7, 2021 - … Airborne Transmission of SARS-CoV-2 Infection in Animal Model New Duke University-led Study Shows That Vaxart's Oral … Airborne Transmission of SARS-CoV-2 Infection in Animal Model October 7, 2021 General Data published in bioRxiv … the airborne transmission of SARS-CoV-2 virus in an animal model.     These results are consistent with those from …
News

Vaxart Announces Creation of New Scientific and Clinical Advisory Board

Scroll to Top